A pack of Hydroxychloroquine Sulfate medication | Bloomberg
Packets of Hydroxychloroquine Sulfate medication | Bloomberg
Text Size:

Washington: Donald Trump said he was unaware Indian Prime Minister Narendra Modi had banned the export of a drug that the U.S. president believes is effective against coronavirus and said he asked Modi for a supply of the medicine.

“I don’t like that decision. I didn’t hear that was his decision,” Trump said at the White House Monday. “I would be surprised if that was his decision. He would have to tell me that.”

Trump said in a recent phone conversation with the prime minister that the U.S. would “appreciate” allowing a U.S. order of the drug “to come out.”

India announced an export ban on the malaria drug hydroxychloroquine on Sunday. Trump has promoted the drug as a possible coronavirus treatment despite an absence of quality clinical trials for the medicine.

The U.S. had obtained 29 million chloroquine or hydroxychloroquine pills for its medical stockpile, Trump said.

“If he doesn’t allow it to come out, that would be OK, but of course there may be retaliation, why wouldn’t that be,” Trump said. –Bloomberg

Also read: More than ventilators, India needs thousands of coronavirus contact-tracers


Subscribe to our channels on YouTube & Telegram

Why news media is in crisis & How you can fix it

You are reading this because you value good, intelligent and objective journalism. We thank you for your time and your trust.

You also know that the news media is facing an unprecedented crisis. It is likely that you are also hearing of the brutal layoffs and pay-cuts hitting the industry. There are many reasons why the media’s economics is broken. But a big one is that good people are not yet paying enough for good journalism.

We have a newsroom filled with talented young reporters. We also have the country’s most robust editing and fact-checking team, finest news photographers and video professionals. We are building India’s most ambitious and energetic news platform. And have just turned three.

At ThePrint, we invest in quality journalists. We pay them fairly. As you may have noticed, we do not flinch from spending whatever it takes to make sure our reporters reach where the story is.

This comes with a sizable cost. For us to continue bringing quality journalism, we need readers like you to pay for it.

If you think we deserve your support, do join us in this endeavour to strengthen fair, free, courageous and questioning journalism. Please click on the link below. Your support will define ThePrint’s future.

Support Our Journalism

Share Your Views


Please enter your comment!
Please enter your name here